Peering Into China SXT Pharmaceuticals's Recent Short Interest
Portfolio Pulse from Benzinga Insights
China SXT Pharmaceuticals (NYSE:SXTC) has seen a significant decrease in short interest, with a 67.38% drop since the last report. The current short interest stands at 6 thousand shares, or 1.52% of the float, with a short-covering time of approximately 1 day. This decline in short interest may indicate a more bullish sentiment among investors compared to the peer group average of 2.98% short interest as a percentage of float.
January 22, 2024 | 1:00 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
China SXT Pharmaceuticals's short interest has significantly decreased, suggesting a more bullish market sentiment and potentially less downward pressure on the stock price in the short term.
A decrease in short interest typically indicates that investors are less bearish on a stock, which can reduce the likelihood of downward pressure from short selling. As SXTC's short interest is now below the peer average, this could be perceived positively by the market, potentially leading to a short-term increase in the stock price.
CONFIDENCE 80
IMPORTANCE 75
RELEVANCE 100